Company Overview
EverEx, established in August 2019, is a digital healthcare startup committed to improving access to musculoskeletal care through innovative technology. Founded by orthopedic surgeon Dr. Chan Yoon, who brings over a decade of clinical experience, EverEx was created to address the limitations of conventional rehabilitation and deliver smarter, more scalable treatment solutions.
In 2023, the company introduced MORA, a digital rehabilitation exercise platform tailored for musculoskeletal patients. This was followed by the 2024 launch of MORA Vu, a medical device powered by AI-based posture estimation technology. In March 2025, EverEx launched MORA Care, a scalable enterprise solution supporting corporate healthcare programs.
EverEx Rehab, certified as an FDA Class II medical device, is currently distributed in the U.S. market. Meanwhile, MORA Cure has completed confirmatory clinical trials?the first among digital therapeutics for musculoskeletal care in Korea?and is preparing for official regulatory approval.
In May, the company will launch MORA Fit, a posture analysis solution tailored for the fitness industry. All EverEx products are powered by Griffin, the company’s proprietary AI model capable of recognizing 24 key joint points to deliver objective and automated functional assessments.
Every product is co-developed by orthopedic and rehabilitation specialists in collaboration with AI engineers. EverEx continues to enhance its technologies and business operations with strong backing from Korean government agencies such as the Ministry of SMEs and Startups, the Health Insurance Review & Assessment Service, and the Korea Medical Device Safety Information Institute.
EverEx’s solutions are already being used in hospitals and clinics across Korea and abroad, helping transform the future of musculoskeletal care through intelligent technology.
In 2023, the company introduced MORA, a digital rehabilitation exercise platform tailored for musculoskeletal patients. This was followed by the 2024 launch of MORA Vu, a medical device powered by AI-based posture estimation technology. In March 2025, EverEx launched MORA Care, a scalable enterprise solution supporting corporate healthcare programs.
EverEx Rehab, certified as an FDA Class II medical device, is currently distributed in the U.S. market. Meanwhile, MORA Cure has completed confirmatory clinical trials?the first among digital therapeutics for musculoskeletal care in Korea?and is preparing for official regulatory approval.
In May, the company will launch MORA Fit, a posture analysis solution tailored for the fitness industry. All EverEx products are powered by Griffin, the company’s proprietary AI model capable of recognizing 24 key joint points to deliver objective and automated functional assessments.
Every product is co-developed by orthopedic and rehabilitation specialists in collaboration with AI engineers. EverEx continues to enhance its technologies and business operations with strong backing from Korean government agencies such as the Ministry of SMEs and Startups, the Health Insurance Review & Assessment Service, and the Korea Medical Device Safety Information Institute.
EverEx’s solutions are already being used in hospitals and clinics across Korea and abroad, helping transform the future of musculoskeletal care through intelligent technology.
